- cafead   Jul 18, 2020 at 12:32: PM
via Eli Lilly’s experimental treatment for plaque psoriasis beat out Novartis’ vaunted drug Cosentyx in a comparison study. Mirikizumab met all primary endpoints against placebo and secondary endpoints against Cosentyx in the Phase III study, the Indianapolis-based pharma company announced.
article source
article source